Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Return on Sales (2020 - 2025)

Pulse Biosciences (PLSE) has 5 years of Return on Sales data on record, last reported at 66.02% in Q4 2025.

  • For Q4 2025, Return on Sales changed N/A year-over-year to 66.02%; the TTM value through Dec 2025 reached 207.8%, changed N/A, while the annual FY2025 figure was 207.8%, N/A changed from the prior year.
  • Return on Sales reached 66.02% in Q4 2025 per PLSE's latest filing, up from 224.86% in the prior quarter.
  • Across five years, Return on Sales topped out at 5216.33% in Q2 2023 and bottomed at 224.86% in Q3 2025.
  • Average Return on Sales over 4 years is 780.97%, with a median of 24.88% recorded in 2021.
  • Peak YoY movement for Return on Sales: plummeted -20340bps in 2022, then skyrocketed 526915bps in 2023.
  • A 4-year view of Return on Sales shows it stood at 18.27% in 2021, then surged by 5695bps to 1021.89% in 2022, then skyrocketed by 329bps to 4386.0% in 2023, then tumbled by -102bps to 66.02% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 66.02% in Q4 2025, 224.86% in Q3 2025, and 4386.0% in Q3 2023.